Medtronic, Inc. Share Price Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
05-09 | Arecor Therapeutics collaborates with Medtronic on novel insulin | AN |
05-09 | Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development | MT |
Sales 2024 * | 32.24B 2,568B | Sales 2025 * | 33.57B 2,673B | Capitalization | 111B 8,833B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B 363B | Net income 2025 * | 5.24B 418B | EV / Sales 2024 * | 4.13 x |
Net Debt 2024 * | 22.21B 1,769B | Net Debt 2025 * | 21.12B 1,682B | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
23.8
x | P/E ratio 2025 * |
20.6
x | Employees | - |
Yield 2024 * |
3.3% | Yield 2025 * |
3.46% | Free-Float | 99.81% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 25/01/15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 31/05/16 |
Gregory Smith
COO | Chief Operating Officer | 63 | 31/03/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 31/12/12 |
Kendall Powell
BRD | Director/Board Member | 70 | 31/12/06 |
Randall Hogan
BRD | Director/Board Member | 68 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
-4.82% | 182B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B | |
-1.73% | 24.6B |